Human OCT-2 variant peptide chains, nucleic acids, and methods

Details Human OCT-2 variant peptide chains, nucleic acids, and methods Human OCT-2 variant peptide chains, nucleic acids, and methods

2011-02-15

2011-02-15

Nashed, Nashaat T (Department: 1656)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C530S350000, C536S023500, C536S023100

Reexamination Certificate

active

07888117

ABSTRACT:
Homo sapiensOCT-2 variant peptide chains are disclosed. Polynucleotides encoding these peptide chains, cells comprising these polynucleotides, and methods of using the forgoing are also disclosed.

REFERENCES:
patent: 2005/017121 (2005-02-01), None
Jeremy M. Boss, Regulation of transcription of MHC class II genes, Current Opinion in Immunology, 9: 107-113 (1997).
Clerc, et al., “The B-cell-specific Oct-2 protein contains POU box-and homeo box-type domains,” Genes Development, 2: 1570-1581 (1988).
Corcoran, et al., “Oct-2, although not required by early B-cell development, is critical for later B-cell maturation and for postnatal survival,” Genes Development, 7: 570-582 (1993).
Dorai, et al., “Correlation of Heavy and Light Chain mRNA Copy Numbers to Antibody Productivity in Mouse Myelma Production Cell Lines,” Hybridoma, 25(1): 1-9 (2005).
Freundlieb, et al., “A Tetracycline Controlled Activation/Repression System with Increased Potential for Gene Transfer into Mammalian Cells,” The Journal of Gene Medicine, 1: 4-12 (1999).
Liu, et al., “Adjacent proline resides in the inhibitory domain of the Oct-2 transcription factor play distinct functional roles,” Nucleic Acids Research, 26(10): 2464-2472 (1998).
Patrick Matthias, “Lymphoid-specific transcription mediated by the conserved octamer site: Who is doing what?” Immunology, 10: 155-163 (1998).
Müller, et al., “A cloned octamer transcription factor stimulated transcription from lymphoid-specific promoters in non-B cells,” Nature, 336: 544-551 (1988).
Sáez, et al., “Analysis of Octamer-Binding Transcription /Factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in Lymphomas,” Modern Pathology, 15(3): 211-220 (2002).
Strubin, et al. “OBF-1, a novel B-cell specific co-activator that stimulates immunoglobulin promoter activity through association with Octamer binding proteins,” Cell, 80: 497-506 (1995).
Suzuki, et al., “Mouse Oct-1 contains a composite homeodomain of human Oct-1 and Oct-2,” nucleic Acids Research 21(2): 245-252 (1993).
Wirth, et al., “Multiple Oct2 isoforms are generated by alternative splicing,” Nucleic Acids Research, 19(1): 43-51 (1991).
Zhang, et al., “Synthetic Zinc Finger Transcription Factor Action at an Endogenous Chromosomal Site,” The Journal of Biological Chemistry, 275(43): 33850-33860 (2000).
Zwilling, et al., “The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP,” Nucleic Acids Research, 22(9): 1655-1662 (1994).
PCT International Search Report dated Apr. 15, 2008.
Supplemental European Search Report dated Oct. 16, 2009.

Affiliated with

Also associated with

Rating

Human OCT-2 variant peptide chains, nucleic acids, and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human OCT-2 variant peptide chains, nucleic acids, and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human OCT-2 variant peptide chains, nucleic acids, and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2636165